You are currently viewing a new version of our website. To view the old version click .
Diagnostics
  • Correction
  • Open Access

6 February 2025

Correction: Ong et al. Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker. Diagnostics 2023, 13, 2296

,
,
,
,
,
,
,
and
1
Division of Gastroenterology & General Surgery, Department of Surgery, Chi Mei Medical Center, Tainan 710, Taiwan
2
Department of Medical Technology, Chung Hwa University of Medical Technology, Tainan 717, Taiwan
3
Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung 804, Taiwan
4
Division of Hematology and Oncology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei 235, Taiwan
This article belongs to the Special Issue Advanced Pathology and Diagnostics in Gastroenterology and Liver Diseases
In the original publication [], there was a mistake in Figure 3B as published. The group with the poorer outcome in Figure 3B should have been labeled “CPS1 Low Exp”. The corrected Figure 3 appears below.
Figure 3. Kaplan–Meier estimator demonstrated the significantly poorer clinical outcomes, including (A) overall survival (OS), (B) disease-specific survival (DSS), (C) local recurrence-free survival (LRFS) and (D) distant metastasis-free survival (MeFS) in relation to the low expression of CPS1 (all p < 0.0001).
There was an error in the original publication. “Disease-free survival (DFS)” should be replaced with “disease-specific survival (DSS)”.
A correction has also been made to the Abstract:
CPS1 underexpression was not only negatively correlated to overall survival (OS), disease-specific survival (DSS), local recurrence-free survival (LRFS) and metastasis-free survival (MeFS) in univariate analysis but also an independent prognosticator to forecast poorer clinical outcome for all prognostic indices (OS, DSS, LRFS and MeFs) in patients with IHCC (all p ≤ 0.001).
A correction has also been made to the Discussion section, Paragraph 4:
Furthermore, CPS1 underexpression was not only negatively correlated to overall survival (OS), disease-specific survival (DSS), local recurrence-free survival (LRFS) and metastasis-free survival (MeFS) in univariate analysis but also an independent prognosticator to forecast poorer clinical outcome for all prognostic indices (OS, DSS, LRFS and MeFs) in patients with IHCC (all p ≤ 0.001).
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Ong, K.H.; Hsieh, Y.-Y.; Sun, D.-P.; Huang, S.K.-H.; Tian, Y.-F.; Chou, C.-L.; Shiue, Y.-L.; Joseph, K.; Chang, I.-W. Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker. Diagnostics 2023, 13, 2296. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.